Uravi Defence reports lower FY26 profit, revenue declines
Uravi Defence and Technology Limited reported a decline in net profit to ₹131.70 lakh for FY26 from ₹178.58 lakh in the previous year, with revenue from operations falling to ₹3,862.05 lakh. The Board approved the audited results on May 26, 2026, and the statutory auditors issued a modified opinion on the consolidated results due to reliance on unaudited accounts for an associate. The company also divested its stake in SKL India (Private) Limited during the year.

*this image is generated using AI for illustrative purposes only.
Uravi Defence and Technology Limited reported a net profit of ₹131.70 lakh for the financial year ended March 31, 2026, a decline from ₹178.58 lakh in the previous year. Revenue from operations for FY26 stood at ₹3,862.05 lakh, compared to ₹4,134.54 lakh in FY25. The Board of Directors approved the audited standalone and consolidated financial results at a meeting held on May 26, 2026. The results were published in newspapers on May 30, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
The statutory auditors, Viren Gandhi & Co., issued an unmodified opinion on the standalone financial results. However, the report on the consolidated financial results carries a modified opinion. This modification arises because the company relied on unaudited management accounts for its associate, Spafax International Holding Limited, to determine a share of profit of ₹72.05 lakh, as audited financial statements were not available.
Operational and Strategic Updates
During the year, the company completed the sale of its 50.01% shareholding in SKL India (Private) Limited, which ceased to be a subsidiary effective March 18, 2026. The advance of ₹1,125.20 lakh received earlier was adjusted against the sale consideration. Additionally, the company's investment in Spafax International Holding Limited crossed the 20% threshold on February 23, 2026, classifying it as an associate accounted for under the equity method.
Financial Performance
Total income for the year decreased to ₹4,049.20 lakh from ₹4,223.97 lakh in the prior year. Total expenses also reduced to ₹3,870.76 lakh from ₹3,967.82 lakh. For the quarter ended March 31, 2026, the company posted a net profit of ₹21.72 lakh on a total income of ₹1,068.03 lakh.
| Metric | FY26 (₹ in Lakhs) | FY25 (₹ in Lakhs) |
|---|---|---|
| Income from Operations | 3,862.05 | 4,134.54 |
| Total Income | 4,049.20 | 4,223.97 |
| Total Expenses | 3,870.76 | 3,967.82 |
| Net Profit for the Period | 131.70 | 178.58 |
The trading window, closed since April 1, 2026, will reopen 48 hours after the declaration of these results. Kaushik Damji Gada, Whole-time Director & CFO, signed the regulatory filing.
Historical Stock Returns for Uravi Defence and Technology
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.11% | -0.73% | -8.06% | -33.71% | -77.19% | -59.53% |
How will the divestment of SKL India impact Uravi's revenue streams and operational focus in the coming fiscal year?
What strategic benefits does Uravi anticipate from the increased stake in Spafax International Holding Limited crossing the 20% threshold?
When are the audited financial statements for Spafax expected to be available to resolve the modified opinion on the consolidated results?

































